Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
2024-2033 Forecast: What is the Projected Growth Rate for the Extended-Release Drugs Market?
The market for extended-release drugs has seen significant expansion over the recent years. It is projected to increase from $57.11 billion in 2023 to $63.82 billion in 2024, yielding a compound annual growth rate (CAGR) of 11.7%. The surge in growth during the historical period can be linked to several factors like enhanced patient adherence, the surge in chronic disease incidents, better therapeutic effectiveness, patent protection tactics, and the use of biodegradable implants.
The market for extended-release drugs is projected to undergo swift expansion in the upcoming years, reaching a worth of $99.77 billion in 2028, with a compound annual growth rate (CAGR) of 11.8%. This projected increase during the forecast period can be linked to factors such as the application of personalized medicine strategies, focus on patient-centric drug creation, the escalating prevalence of lifestyle-related diseases, the reassessment of drug usage, and worldwide access to extended-release treatments. The forecast period is characterized by notable trends such as pharmaceutical advancements, progress in drug administration systems and nanotechnology, the application of 3D printing in drug creation, the implementation of artificial intelligence, and emphasis on environmental sustainability.
Claim Your Free Sample of the Global Extended-Release Drugs Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12675&type=smp
What Are the Main Drivers Behind the Growth of the extended-release drugs Market?
The rise in chronic illnesses is anticipated to spur the expansion of the extended-release pharmaceutical market in the future. Chronic illnesses are classified as conditions that endure for a year or longer, necessitating continuous medical care, imposing limits on daily tasks, or both. Examples include heart disease, cancer, obesity, and diabetes. Extended-release medication systems are created to maintain a relatively stable concentration of the drug in the body for a lengthy period of time. This assists in maintaining a consistent therapeutic result and prevents the changes in drug concentrations that can happen with immediate-release medicines. For instance, the National Center for Biotechnology Information (NCBI), a national medical library based in the US, forecasted in January 2023 that by 2050, there will be a 99.5% increase in the number of individuals aged 50 and above suffering from at least one chronic disease, escalating to 142.66 million. Hence, the escalating prevalence of chronic diseases is fueling the growth of the extended-release drug market.
What Are the Primary Segments of the Extended-Release Drugs Market?
1) By Type: Sustained Release Drug, Controlled Release Drug
2) By Mode: Over-The-Counter, Prescription
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies, Drug Stores
Which Trends Are Revolutionizing the Extended-Release Drugs Market?
The escalating trend of product innovation is becoming increasingly significant in the extended-release drug market. Key players in this market are creating inventive products to maintain their market stance. Zydus Pharmaceuticals (USA) Inc., an American manufacturer of generic pharmaceuticals, exemplified this trend in July 2022, by launching Topiramate extended-release capsules used for epilepsy treatment. Prior to this, the US Food and Drug Administration (USFDA) had approved the company to trade Topiramate extended-release capsules, USP 25 mg, 50 mg, and 100 mg; marking it as the foremost business in the US to gain full approval and proceed with the introduction of Topiramate extended-release capsules. Topiramate extended-release capsules have received clearance for application in two forms for patients with partial onset or primary generalized tonic-clinic seizure.
Order Now for Fast Delivery of Your Extended-Release Drugs Market Report!
https://www.thebusinessresearchcompany.com/report/extended-release-drugs-global-market-report
Which Geographical Regions Are Pioneering Growth in the Extended-Release Drugs Market?
North America was the largest region in the extended-release drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the extended-release drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Extended-Release Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the extended-release drugs market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Extended-Release Drugs Market Include
1. Extended-Release Drugs Market Executive Summary
2. Extended-Release Drugs Market Segments
3. Extended-Release Drugs Market Size And Template Market Growth Rate
4. Key Extended-Release Drugs Market Trends
5. Major Extended-Release Drugs Market Drivers
……
25. Key Mergers And Acquisitions In The Extended-Release Drugs Market
26. Top Extended-Release Drugs Companies
27. Extended-Release Drugs Market Opportunities And Strategies
28. Extended-Release Drugs Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Central Nervous System Drugs Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/central-nervous-system-drug-global-market-report
Drug Eluting Stent Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-eluting-stent-global-market-report
Drugs for Immunotherapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
